Novavax’s dispute resolution and upcoming earnings call
Jeffrey Neal Johnson
Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.
NASDAQ:NVAXNYSE:PFENASDAQ:MRNA